123 related articles for article (PubMed ID: 12657119)
1. Use of small pelvic field instead of whole pelvic field in postoperative radiotherapy for node-negative, high-risk stages I and II cervical squamous cell carcinoma.
Ohara K; Tsunoda H; Nishida M; Sugahara S; Hashimoto T; Shioyama Y; Hasezawa K; Yoshikawa H; Akine Y; Itai Y
Int J Gynecol Cancer; 2003; 13(2):170-6. PubMed ID: 12657119
[TBL] [Abstract][Full Text] [Related]
2. Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion.
Uno T; Ito H; Isobe K; Kaneyasu Y; Tanaka N; Mitsuhashi A; Suzuka K; Yamazawa K; Shigematsu N; Itami J
Gynecol Oncol; 2005 Feb; 96(2):335-40. PubMed ID: 15661218
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant pelvic irradiation in patients with pathologic T2b carcinoma of the uterine cervix.
Uno T; Ito H; Itami J; Sato T; Minoura S; Yasuda S; Aruga T; Isobe K; Shigematsu N; Kubo A
Int J Gynecol Cancer; 2002; 12(2):187-91. PubMed ID: 11975678
[TBL] [Abstract][Full Text] [Related]
6. Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis.
Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Lee SP; Tseng CJ; Hsueh S
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1284-90. PubMed ID: 12128131
[TBL] [Abstract][Full Text] [Related]
7. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
[TBL] [Abstract][Full Text] [Related]
8. Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity.
Zhang G; He F; Miao L; Wu H; Zhang Y; Fu C
Jpn J Clin Oncol; 2021 May; 51(6):905-910. PubMed ID: 33822980
[TBL] [Abstract][Full Text] [Related]
9. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
10. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
12. Use of the small pelvic field instead of the classic whole pelvic field in postoperative radiotherapy for cervical cancer: reduction of adverse events.
Ohara K; Tsunoda H; Satoh T; Oki A; Sugahara S; Yoshikawa H
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):258-64. PubMed ID: 15337564
[TBL] [Abstract][Full Text] [Related]
13. Reduction of late complications after irregularly shaped four-field whole pelvic radiotherapy using computed tomographic simulation compared with parallel-opposed whole pelvic radiotherapy.
Yamazaki A; Shirato H; Nishioka T; Hashimoto S; Kitahara T; Kagei K; Miyasaka K
Jpn J Clin Oncol; 2000 Apr; 30(4):180-4. PubMed ID: 10830986
[TBL] [Abstract][Full Text] [Related]
14. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
15. Is postoperative radiotherapy beneficial in the management of stage I-II squamous-cell carcinoma of the uterine cervix with negative metastatic nodes and positive parametrial involvement?: A retrospective review of 70 patients.
Takamura A; Mizoe J; Arimoto T; Kamada T; Shirato H; Matsuoka Y; Tomita M; Irie G
Asia Oceania J Obstet Gynaecol; 1993 Jun; 19(2):145-51. PubMed ID: 8379861
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
17. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
18. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
Yeh SA; Wan Leung S; Wang CJ; Chen HC
Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
[TBL] [Abstract][Full Text] [Related]
20. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
Tuipae S; Yanaranop M; Oniem N
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
